Skip to main content
    B

    bioAffinity Technologies, Inc. (BIAF)

    Official site

    HEALTHCARE • DIAGNOSTICS & RESEARCH • NASDAQ

    $1.93
    -0.07 (-3.50%)

    Market Cap: $4.00M

    Last updated: Nov 17, 2026 at 4:24 PM ET

    bioAffinity Technologies, Inc. (BIAF) Statistics

    Updated Nov 17, 2026. Figures from company filings and market prices; estimates from consensus analysts.

    bioAffinity Technologies (BIAF) has a market cap of $4.00M and an enterprise value of $1.63M. It kept -278.93% of revenue as net income over the last 12 months. It holds $2.37M more cash than debt, 59.22% of its market cap.

    Total Valuation

    Enterprise value is 59.22% below the market cap, as cash exceeds debt.

    Market Cap$4.00M
    Enterprise Value$1.63M
    Latest price (Nov 17, 2026)$1.93

    Key Dates

    The next earnings report is expected on Mar 11, 2027, covering the quarter ending Dec 31, 2026.

    Next Earnings DateMar 11, 2027 (expected)
    Last Earnings DateNov 6, 2026
    Fiscal Year EndDecember

    Valuation Ratios

    Sales and book value multiples are 0.3x and 0.4x.

    P/S Ratio0.3x
    Forward P/S0.5x
    P/B Ratio0.4x
    P/TBV Ratio0.9x

    Price Statistics

    The stock is down 93.01% over 52 weeks and trades 61.09% below its 50-day average.

    Beta (1Y)2.01
    52-Week Change-93.01%
    1-Month Change-45.01%
    3-Month Change-68.54%
    6-Month Change-92.43%
    Total Return (1Y)-93.01%
    Total Return (3Y CAGR)-85.44%
    Return vs SPY (1Y)-102.81%
    Max Drawdown (1Y)-97.29%
    Max Drawdown (3Y)-99.86%
    Sharpe Ratio (1Y)-1.33
    Correlation with SPY (1Y)0.15
    50-Day Average$4.96
    200-Day Average$18.23
    52-Week Range$1.96 to $80.70
    RSI (14 Days)29.8
    Average Volume (20 Days)90.85K

    Price chart

    Financial Position

    Current assets cover 1.51x current liabilities, and total debt is 0.05x shareholder equity.

    Current Ratio1.51x
    Quick Ratio1.47x
    Debt / Equity0.05x
    Interest Coverage-306.74x

    Returns and Efficiency

    Return on invested capital is -376.12% and return on equity is -393.69% over the last 12 months.

    Return on Equity (ROE)-393.69%
    Return on Assets (ROA)-204.02%
    Return on Invested Capital (ROIC)-376.12%
    Return on Capital Employed (ROCE)-306.66%
    Asset Turnover0.58x
    Receivables Turnover6.75x

    Scores

    BIAF has an Altman Z-Score of -20.48, in the distress zone below 1.81, and a Piotroski F-Score of 3 of 9, in the average band of 3 to 7.

    Altman Z-Score-20.48
    Altman Z ZoneDistress
    Piotroski F-Score3 of 9
    Piotroski StrengthAverage

    Income Statement

    Revenue of $5.53M over the last 12 months is down 18.47% from the 12 months before.

    Revenue$5.53M
    Revenue Growth (YoY)-18.47%
    Gross Profit$5.53M
    Operating Income-$13.60M
    Pretax Income-$15.41M
    Net Income-$15.41M
    EBIT-$15.40M
    Reported EPS (TTM)-$15.85

    Trailing 12 months through Sep 30, 2026.

    Full financial statements

    Balance Sheet

    Shareholder equity funds 51.79% of the $7.55M in total assets.

    Cash and Equivalents$2.55M
    Total Debt$178.67K
    Net Cash$2.37M
    Net Cash Per Share$2.65
    Working Capital$1.29M
    Shareholder Equity$3.91M
    Book Value Per Share$4.37
    Tangible Book Value$1.84M
    Tangible Book Per Share$2.05
    Total Assets$7.55M
    Total Liabilities$3.64M

    Balance sheet as of Sep 30, 2026.

    Full balance sheet

    Cash Flow

    After $172.68K of capital spending, operating cash flow left -$13.03M of free cash flow.

    Operating Cash Flow-$12.86M
    Capital Expenditures$172.68K
    Free Cash Flow-$13.03M
    FCF Per Share-$10.16
    Depreciation and Amortization$366.57K

    Trailing 12 months through Sep 30, 2026.

    Full cash flow statement

    Margins

    The operating margin is -246.14%.

    Gross Margin100.00%
    Operating Margin-246.14%
    Pretax Margin-278.87%
    Net Margin-278.93%
    EBIT Margin-278.64%
    FCF Margin-235.89%

    Dividends and Yields

    BIAF does not pay a dividend. Its free cash flow yield is -753.47%.

    FCF Yield-753.47%
    Buyback Yield-344.43%
    Shareholder Yield-344.43%

    Stock Splits

    The last split was a 1-for-15 reverse split on Aug 24, 2026.

    Last Split DateAug 24, 2026
    Split TypeReverse split
    Split Ratio1:15

    Peer Position

    Against 6 similar companies, BIAF has the 6th highest P/S.

    P/S Ratio0.3x vs 1.6x median
    ROIC-376.12% vs -14.34% median
    Revenue Growth (Trailing 4 Quarters, YoY)-18.47% vs -50.00% median

    Competitors compared

    Analyst Forecast

    Consensus estimates put revenue growth at 18.58% a year over the next fiscal year.

    Revenue Growth Forecast (1Y CAGR)+18.58%

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    Frequently Asked Questions About BIAF

    What is BIAF's market cap?

    bioAffinity Technologies has a market cap of $4.00M. Its enterprise value, which adds debt and subtracts cash, is $1.63M.

    How many shares of BIAF are outstanding?

    bioAffinity Technologies has 896.27K shares outstanding.

    Does BIAF pay a dividend?

    No. bioAffinity Technologies does not pay a dividend.

    How much debt does BIAF have?

    bioAffinity Technologies has $178.67K of total debt and $2.55M of cash and equivalents, a net cash position of $2.37M.